Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib + Lenalidomide + Dexamethasone in NDMM
NCT01383928Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Oct 2011; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01383928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01383928.